Wednesday, February 26, 2014 - Thursday, February 27, 2014
7:00 a.m. - 5:00 p.m.
Add to Calendar
Monday, February 24, 2014 5:00 p.m.
Where The Lodge at Torrey Pines
11480 North Torrey Pines Road
La Jolla, California 92037
The Premier Partnering Event of 2014
Biocom's fourth annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives and business development professionals from leading pharmaceutical and biotech companies.
The conference will include case study presentations, panel discussions on relevant topics with senior industry leaders, individual company presentations, one-on-one meetings, and numerous networking opportunities.
Click HERE to see the full conference agenda
Stanley T. Crooke, Chairman of the Board & Chief Executive Officer, Isis Pharmaceuticals
Howard Asher, EVP, Sales and Marketing, Abnology
Miranda Biven, Partner, Wilson Sonsini Goodrich & Rosati
Graham Brazier, Vice President, Business Development, Bristol-Myers Squibb Company
Remi Brouard, Vice President External Innovation, Sanofi
John Diekman, Founding & Managing Partner, 5AM Ventures
C. Simone Fishburn, Senior Editor, BioCentury
George Golumbeski, Senior Vice President of Business Development, Celgene
Faheem Hasnain, President and CEO, Receptos
Rich Heyman, CEO, Seragon Pharmaceuticals
Robin Jackman, CEO, Leading BioSciences
Chau Khoung, Private Equity Partner, OrbiMed Advisors, LLC
Reid Leonard, Managing Director, Merck Research Ventures, Merck & Co., Inc.
Jay Lichter, Managing Director, Avalon Ventures
Damien McDevitt, VP & Head of BD for R&D Extended Therapy Areas, Head of R&D West Coast Hub, Worldwide Business Development, GlaxoSmithKline Pharmaceuticals
Diego Miralles, Global Head of Innovation, Janssen Pharmaceuticals
Keith Murphy, Chairman & CEO, Organovo
Carole Neuchterlein, Head, Roche Venture Fund
Michael J. O'Donnell, Partner, Morrison & Foerster
Terry Porter, Vice President, Search & Evaluation,Global BD, Takeda Pharmaceuticals
Uwe Schoenbeck, Senior Vice President & Chief Scientific Officer, External R&D Innovation, WRD, Pfizer, Inc.
Jeff Stein, Principal, JLS Advisers, LLC
Michael Step, SVP Corporate Development, Santarus, Inc.
Mary Thistle, Senior Vice President Business Development, Cubist Pharmaceuticals
Jack Tupman, Vice President, Corporate Business Development, Eli Lilly & Company
Richard Ulevitch, Venture Partner, 5AM Ventures
Kurt von Emster, Founding Partner, venBio
Randall E. Woods, President and CEO, Sophiris Bio
Kleanthis G. Xanthopoulos, Ph.D., President and Chief Executive Officer, Regulus Therapeutics
Barbara Yanni, Vice President and Chief Licensing Officer, Merck
Chihiro Yokota, Global Head of Business Development and Licensing & Alliances, Astellas Pharma Inc.
Krisztina Zsebo, President & CEO, Celladon Corporation
Igor Bilinsky, SVP Corporate Development, Vical Inc.
Jennifer Cayer, Former Chief Operating Officer, Rempex Pharmaceuticals
Jim Schaeffer, Executive Director, Merck
Mark Wiggins, Senior VP of Business Development, Elcelyx Therapeutics
Planner Ashleigh Berry